2,950
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment

, , , &
Pages 59-69 | Received 16 Oct 2017, Accepted 01 Dec 2017, Published online: 12 Dec 2017

References

  • Adibkia K, Omidi Y, Siahi MR, et al. (2007). Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J Ocul Pharmacol Ther 23:421–32.
  • Aiello LP, Brucker AJ, Chang S, et al. (2004). Evolving guidelines for intravitreous injections. Retina 24:3–19.
  • Allahham A, Mainwaring D, Stewart P, et al. (2004). Development and application of a micro-capillary rheometer for in-vitro evaluation of parenteral injectability. J Pharm Pharmacol 56:709–16.
  • Andrews GP, Donnelly L, Jones DS, et al. (2009). Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery. Biomacromolecules 10:2427–35.
  • Avery RL, Bakri SJ, Blumenkranz MS, et al. (2014). Intravitreal injection technique and monitoring: undated guidelines of an expert panel. Retina 34:1–18.
  • Bourges JL, Bloquel C, Thomas A, et al. (2006). Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev 58:1182–202.
  • Cantrill HL, Henry K, Melroe NH, et al. (1989). Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results. Ophthalmology 96:367–74.
  • Chien Y. (1991). Novel drug delivery systems. 2nd ed. Oxfordshire: Taylor & Francis.
  • Choonara YE, Pillay V, Carmichael T, et al. (2006). An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation. Int J pharmaceut 310:15–24.
  • Choopong P, Tesavibul N, Rodanant N. (2010). Crystallization after intravitreal ganciclovir injection. Clin Ophthalmol 4:709–11.
  • Cilurzo F, Selmin F, Minghetti P, et al. (2011). Injectability evaluation: an open issue. AAPS PharmSciTech 12:604–9.
  • Cochereau-Massin I, Le Hoang P, Lautier-Frau M, et al. (1991). Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 98:1348–55.
  • Doring A, Birnbaum W, Kuckling D. (2013). Responsive hydrogels – structurally and dimensionally optimized smart frameworks for applications in catalysis, micro-system technology and material science. Chem Soc Rev 42:7391–420.
  • Edsman K, Carlfor J, Peterson R. (1998). Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 6:105–12.
  • Freeman WR, Lerner CW, Mines JA, et al. (1984). A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 97:133–42.
  • Gilbert JC, Richardson JL, Davis MC, et al. (1987). The effect of solutes and polymer on the geleation properties of pluronic F-127 solution for controlled drug delivery. J Control Release 5:113–8.
  • Grassi G, Crevatin A, Farra R, et al. (2006). Rheological properties of aqueous Pluronic–alginate systems containing liposomes. J Colloid Interf Sci 301:282–90.
  • He C, Kim SW, Lee DS. (2008). In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release 127:189–207.
  • Hinkle AM, Lee JA, Bell KA, et al. (2000). A review of antiviral therapies in the treatment of cytomegalovirus. Dermatol Ther 13:269–76.
  • Hoffman AS. (2002). Hydrogels for biomedical applications. Adv Drug Deliv Rev 54:3–12.
  • Huynh CT, Nguyen MK, Lee DS. (2011). Injectable block copolymer hydrogels: achievements and future challenges for biomedical applications. Macromolecules 44:6629–36.
  • Janoria KG, Boddu SH, Wang Z, et al. (2009). Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J Ocul Pharmacol Ther 25:39–49.
  • Macha S, Mitra AK. (2002). Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab Dispos 30:670–5.
  • Martin DF, Sierra-Madero J, Walmsley S, et al. (2002). A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346:1119–26.
  • Mathew P, Scott C, Dennis K, et al. (2014). Tuning gelation time and morphology of injectable hydrogels using Ketone − Hydrazide cross-linking. Biomacromolecules 15:781–90.
  • Mitra AK. (1993). Ophthalmic drug delivery systems. 2nd ed. Oxfordshire: Taylor & Francis.
  • National Pharmacopoeia Committee. (2015). Pharmacopoeia of People’s Republic of China, Part 4, 0105. 1st ed. Beijing: Chemical Industry Press.
  • Nussenblatt RB, Lane HC. (1998). Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 125:374–82.
  • Ricci EJ, Brntley MV, Farah M, et al. (2002). Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci 17:161–7.
  • Schindler A, Hibionada YM, Pitt CG. (1982). Aliphatic polyesters. III. Molecular weight and molecular weight distribution in alcohol‐initiated polymerizations of ϵ-caprolactone. J Polym Sci Polym Chem Ed 20:319–26.
  • Smith TJ, Pearson PA, Blandford DL, et al. (1992). Intravitreal sustained-release ganciclovir. Arch Ophthalmol 110:255–8.
  • Tokarev I, Minko S. (2010). Stimuli-responsive porous hydrogels at interfaces for molecular filtration, separation, controlled release, and gating in capsules and membranes. Adv Mater Weinheim 22:3446–62.
  • Voigt M, Koerber M, Bodmeier R. (2012). Improved physical stability and injectability of non-aqueous in situ PLGA microparticle forming emulsions. Int J Pharmaceut 434:251–6.
  • Wen Y, Kolonich HR, Kruszewski KM, et al. (2013). Retaining antibodies in tumors with a self-assembling injectable system. Mol Pharmaceutics 10:1035–44.
  • Wen Y, Liu W, Bagia C, et al. (2014a). Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta biomater 10:4759–67.
  • Wen Y, Roudebush SL, Buckholtz GA, et al. (2014b). Coassembly of amphiphilic peptide EAK16-II with histidinylated analogues and implications for functionalization of β-sheet fibrils in vivo. Biomaterials 35:5196–205.
  • Xi L, Wang T, Zhao F, et al. (2014). Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery. PLoS One 9:e100632.
  • Xu XF, Shen Y, Wang W, et al. (2014a). Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride. Eur J Pharm Biopharm 88:998–1004.
  • Xu YR, Shen Y, Xiong YR, et al. (2014b). Synthesis, characterization, biodegradability and biocompatibility of a temperature-sensitive PBLA-PEG-PBLA hydrogel as protein delivery system with low critical gelation concentration. Drug Dev Ind Pharm 40:1264–75.
  • Xu YR, Shen Y, Ouahab A, et al. (2015). Antitumor activity of TNF-α after intratumoral injection using an in situ thermosensitive hydrogel. Drug Dev Ind Pharm 41:369–74.